- Citations, last 5 years
- 199k
- Works, last 5 years
- 15.7k
- h-index
- 1,134
- Scientists listed
- 827
- Grants since 2016
- 1 652
Grants received
2017–2020 · cooperative agreement · UG3
ReCAPSE: Recurrence from Claims And PROs for SEER Enhancement
Jessica Chubak · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Targeting a Novel Hematopoietic Stem Cell Population in Non-Human Primates for Effective and Sustained Gene Therapy
Hans-Peter Kiem · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R50
Defining and targeting mechanisms of pancreas cancer pathogenesis
Martin Whittle · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · cooperative agreement · U01
Personalized cancer models to discover and develop new therapeutic targets.
Christopher J Kemp · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Differentiation balances oncogene-driven proliferation to maintain epidermal homeostasis
Slobodan Beronja · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Maternal-infant Virome Transmission: the role of HIV and Antiretroviral Therapy
Dara Ann Lehman · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Improving treatment of cardiovascular risk factors in childhood cancer survivors
Eric Jessen Chow · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2019 · cooperative agreement · UG3
ReCAPSE: Recurrence from Claims And PROs for SEER Enhancement
Jessica Chubak · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2020 · research · R21
Exploring Invasive Placentation as a Marker of Cancer Risk in Women and Offspring
Beth A Mueller · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Differentiation balances oncogene-driven proliferation to maintain epidermal homeostasis
Slobodan Beronja · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R35
Mechanisms regulating nuclear envelope structure and stability
Emily M Hatch · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Big Flow Cytometry Data: Data Standards, Integration and Analysis
Greg Finak · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2019 · fellowship · F32
The effect of local inter-nucleosomal interactions and chromatin remodeling on in vivo chromatin fiber folding
Sarah Grace Swygert · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R25
Pathways to Cancer Research
Jeanne Ting Chowning · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · Global Health
Fred Hutchinson Cancer Center - to support a test of concept efficacy trial to determine if a novel experimental HIV vaccine prevents HIV infection in women in southern Africa who...
Fred Hutch Cancer Center · funded by Bill and Melinda Gates Foundation
2017–2022 · research · R01
Predicting PrEP Uptake and Adherence among Adolescent Girls and Young Women in Sub-Saharan Africa: Leveraging Programmatic and Clinical Trials Data
Ying Qing Chen · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R25
Pathways to Cancer Research
Jeanne Ting Chowning · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2019 · fellowship · F32
Hybrid Glycoproteomic and Autoantibody Biomarkers for Lung Cancer Early Detection
Kristin J Lastwika · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Anti-CD38 targeted alpha emitter radioimmunotherapy to eliminate multiple myeloma
Damian J. Green · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Maternal-infant Virome Transmission: the role of HIV and Antiretroviral Therapy
Dara Ann Lehman · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2020 · career development · K08
Novel targeted therapies for isocitrate dehydrogenase mutantcholangiocarcinoma
Supriya K Saha · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2020 · research · R00
Deciphering the role of Lin28b in pancreatic cancer to guide therapeutic discovery
Sita Kugel · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
The Gut Microbiota and Graft versus Host Disease (GVHD)
David Neal Fredricks · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R35
Investigating how cellular mechanisms interface to maintain energy balance
Akhila Rajan · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2020 · research · R01
Novel Gene Editing Approaches for Hemoglobinopathies
Hans-Peter Kiem · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2019 · research · R21
Role of FA-BRCA pathway in stem cell resistance to acetaldehyde
Silvia Balbo · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R50
Advanced statistical modeling and analytics for prostate cancer interventions
Roman Gulati · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Anti-CD38 targeted alpha emitter radioimmunotherapy to eliminate multiple myeloma
Damian J. Green · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Integrating health informatics in a scalable stepped care self-management program for survivors after hematopoietic cell transplantation
Kevin S Baker · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
The SyngenicDNA and μPOET Platform: Overcoming Innate Barriers to Genetic Engineering in Bacteria.
Christopher D Johnston · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
An Academic-Industry Partnership to Advance Functional Genomics for Personalized Oncology.
Christopher J Kemp · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2019 · research · R21
Exploring Invasive Placentation as a Marker of Cancer Risk in Women and Offspring
Beth A Mueller · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2021 · research · R01
Rational design and functionalization of circular tandem repeat proteins
Philip Bradley · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2020 · research · R21
The effect of peri-mucositis and peri-implantitis on innate-like T cell function and anti-bacterial immunity
Douglas Raymond Dixon · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Immuno and Epigenetics of Hematopoietic Cell Transplantation
Effie W Petersdorf · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Immuno and Epigenetics of Hematopoietic Cell Transplantation
Effie W Petersdorf · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2019 · research · R21
Engineered CTLA4-targeted agonists as therapeutic immunomodulators
Roland K Strong · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
The Gut Microbiota and Graft versus Host Disease (GVHD)
David Neal Fredricks · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2019 · research · R21
The effect of peri-mucositis and peri-implantitis on innate-like T cell function and anti-bacterial immunity
Douglas Raymond Dixon · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
The SyngenicDNA and ÃÂÃÂÃÂüPOET Platform: Overcoming Innate Barriers to Genetic Engineering in Bacteria.
Christopher D Johnston · Fred Hutch Cancer Center · funded by National Institutes of Health
